Home » Topics » Science » New compound

New compound
RSS

BAY-2476568, a reversible, potent and selective EGFR inhibitor for lung cancer

April 13, 2021

Naphthalene monoimide TGR-63 for treating Alzheimer's disease

April 9, 2021

VB-85247, a member of a novel class of macrocyclic STING agonists

April 8, 2021

Unnatural Products describes MDM2/4 bispecific inhibitor UNP-1797

April 7, 2021

Bile acid sequestrant SAR-442357 improves experimental type 2 diabetes and comorbidities

April 7, 2021

Yhhu-2407, novel low systemic DGAT1 inhibitor with potential for the treatment of dyslipidemia

March 31, 2021

Daiichi Sankyo compound inhibits G9a/GLP to induce fetal hemoglobin production

March 30, 2021

Arenobufagin derivative ZM-226 has antitumor activity with low cardiotoxicity

March 30, 2021

SF-1 antagonist OR-449 for treating ACC

March 25, 2021

Identification and preclinical evaluation of new gamma-secretase modulators to prevent and treat AD

March 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...